Cite
Huang P, Li YY, Park JE, et al. Effects of Onabotulinum Toxin A on Gait in Parkinson's Disease Patients with Foot Dystonia. Can J Neurol Sci. 2021;1-6doi: 10.1017/cjn.2021.42.
Huang, P., Li, Y. Y., Park, J. E., Huang, P., Xiao, Q., Wang, Y., Chen, S., Chen, S. D., Liu, J., & Wu, Y. W. (2021). Effects of Onabotulinum Toxin A on Gait in Parkinson's Disease Patients with Foot Dystonia. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1-6. https://doi.org/10.1017/cjn.2021.42
Huang, Pei, et al. "Effects of Onabotulinum Toxin A on Gait in Parkinson's Disease Patients with Foot Dystonia." The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques vol. (2021): 1-6. doi: https://doi.org/10.1017/cjn.2021.42
Huang P, Li YY, Park JE, Huang P, Xiao Q, Wang Y, Chen S, Chen SD, Liu J, Wu YW. Effects of Onabotulinum Toxin A on Gait in Parkinson's Disease Patients with Foot Dystonia. Can J Neurol Sci. 2021 Mar 09;1-6. doi: 10.1017/cjn.2021.42. Epub 2021 Mar 09. PMID: 33685541.
Copy
Download .nbib